CCRM is a Canadian not-for-profit funded by the Government of Canada, and leading academic and industry partners. It supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. CCRM has a 40,000 square foot space dedicated to advanced cell manufacturing that includes a Good Manufacturing Practices facility for producing cells and viral vectors. CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients. CCRM is the commercialization partner of the University of Toronto’s Medicine by Design. Visit www.ccrm.ca.